Running out of options: Extensively drug-resistant urinary tract infection in an infant.
作者信息
Mijovic Hana, Wakeham Susan, Ng Karen, Al-Rawahi Ghada N, Tilley Peter, Ho Louisa, Roberts Ashley
机构信息
Department of Pediatrics, Division of Infectious Diseases, University of British Columbia and BC Children's Hospital, Vancouver, British Columbia.
Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario.
出版信息
Paediatr Child Health. 2019 Sep;24(6):371-373. doi: 10.1093/pch/pxz048. Epub 2019 Apr 9.
Abstract
摘要
相似文献
1
Running out of options: Extensively drug-resistant urinary tract infection in an infant.无计可施：一名婴儿的广泛耐药性尿路感染
Paediatr Child Health. 2019 Sep;24(6):371-373. doi: 10.1093/pch/pxz048. Epub 2019 Apr 9.
2
Community-onset carbapenem-resistant Klebsiella pneumoniae urinary tract infections in infancy following NICU hospitalisation.新生儿重症监护病房（NICU）住院后婴儿期社区获得性耐碳青霉烯类肺炎克雷伯菌尿路感染
J Pediatr Urol. 2017 Oct;13(5):495.e1-495.e6. doi: 10.1016/j.jpurol.2017.02.008. Epub 2017 Mar 11.
3
Antibiotic resistance in children with recurrent or complicated urinary tract infection.复发性或复杂性尿路感染患儿的抗生素耐药性
JNMA J Nepal Med Assoc. 2009 Jan-Mar;48(173):14-9.
4
Incidence of single-drug resistant, multidrug-resistant and extensively drug-resistant Escherichia coli urinary tract infections: An Australian laboratory-based retrospective study.单药耐药、多药耐药和广泛耐药大肠埃希菌尿路感染的发生率：一项基于澳大利亚实验室的回顾性研究。
J Glob Antimicrob Resist. 2019 Mar;16:254-259. doi: 10.1016/j.jgar.2018.10.026. Epub 2018 Nov 6.
5
Use of Ceftazidime-avibactam for the Treatment of Extensively drug-resistant or Pan drug-resistant Klebsiella pneumoniae in Neonates and Children <5 Years of Age.头孢他啶-阿维巴坦治疗新生儿和<5 岁儿童广泛耐药或全耐药肺炎克雷伯菌感染
Pediatr Infect Dis J. 2019 Aug;38(8):812-815. doi: 10.1097/INF.0000000000002344.
6
The impact of running versus interrupted anastomosis on ureterointestinal stricture rate after radical cystectomy.根治性膀胱切除术后，跑步与间断吻合对输尿管-肠吻合口狭窄发生率的影响。
J Urol. 2013 Sep;190(3):923-7. doi: 10.1016/j.juro.2013.02.091. Epub 2013 Feb 27.
7
Biofilm Production and Antimicrobial Resistance among Uropathogens in Pediatric Cases: a Hospital Based Study.
J Nepal Health Res Counc. 2018 Jul 3;16(2):178-183.
8
Risk factors for nursing- and healthcare-associated urinary tract infection.护理和医疗保健相关尿路感染的危险因素。
Geriatr Gerontol Int. 2018 Aug;18(8):1183-1188. doi: 10.1111/ggi.13438. Epub 2018 May 17.
9
A clinical approach to multidrug-resistant urinary tract infection and subclinical bacteriuria in dogs and cats.犬猫多重耐药性尿路感染和亚临床菌尿的临床处理方法
N Z Vet J. 2020 Mar;68(2):69-83. doi: 10.1080/00480169.2019.1689196. Epub 2019 Nov 28.
10
Nosocomial urinary tract infections in children in a pediatric intensive care unit: a follow-up after 10 years.儿科重症监护病房儿童医院获得性尿路感染：10年后的随访
Pediatr Crit Care Med. 2003 Jan;4(1):74-7. doi: 10.1097/00130478-200301000-00015.
本文引用的文献
1
An emerging multidrug-resistant bacteria.一种新出现的多重耐药细菌。
CMAJ. 2017 Sep 5;189(35):E1115. doi: 10.1503/cmaj.170110.
2
Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.由耐碳青霉烯类与碳青霉烯类敏感革兰氏阴性微生物引起的儿童血流感染：危险因素与结局
Diagn Microbiol Infect Dis. 2017 Apr;87(4):359-364. doi: 10.1016/j.diagmicrobio.2016.12.013. Epub 2017 Jan 3.
3
Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.印度耐碳青霉烯类肠杆菌科细菌血流感染儿童死亡的临床和细菌学危险因素
Pediatr Infect Dis J. 2017 Jun;36(6):e161-e166. doi: 10.1097/INF.0000000000001499.
4
The Use of Systemic and Topical Fluoroquinolones.全身及局部应用氟喹诺酮类药物
Pediatrics. 2016 Nov;138(5). doi: 10.1542/peds.2016-2706.
5
How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals?我们应如何应对人类和动物中出现的质粒介导的黏菌素耐药性？
Int J Infect Dis. 2017 Jan;54:77-84. doi: 10.1016/j.ijid.2016.11.415. Epub 2016 Nov 30.
6
Carbapenem-Resistant Enterobacteriaceae Infections in Children.儿童耐碳青霉烯类肠杆菌科细菌感染
Curr Infect Dis Rep. 2016 Jan;18(1):2. doi: 10.1007/s11908-015-0510-9.
7
Epidemiologic and Genotypic Review of Carbapenemase-Producing Organisms in British Columbia, Canada, between 2008 and 2014.2008年至2014年加拿大不列颠哥伦比亚省产碳青霉烯酶微生物的流行病学和基因型综述
J Clin Microbiol. 2016 Feb;54(2):317-27. doi: 10.1128/JCM.02289-15. Epub 2015 Nov 25.
8
Osteomyelitis due to multiple carbapenemase-producing Gram-negative bacteria: The first case report of a GES-13-producing Pseudomonas aeruginosa isolate in Canada.产多种碳青霉烯酶革兰氏阴性菌导致骨髓炎：加拿大首例产 GES-13 的铜绿假单胞菌分离株的病例报告。
Can J Infect Dis Med Microbiol. 2014 Jul;25(4):229-31. doi: 10.1155/2014/657047.
9
Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children.住院患儿中由耐碳青霉烯类革兰氏阴性病原体引起的感染。
Pediatr Infect Dis J. 2013 Apr;32(4):e151-4. doi: 10.1097/INF.0b013e3182804b49.
10
Ciprofloxacin safety in paediatrics: a systematic review.环丙沙星在儿科中的安全性：系统评价。
Arch Dis Child. 2011 Sep;96(9):874-80. doi: 10.1136/adc.2010.208843. Epub 2011 Jul 23.
Zotero 插件